Physician profile
Glenn L Bugay
NPI 1194732974
$609.38
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $362 · 2020: $234 · 2023: $13.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $157.86 | 2019-2020 | |
| Lilly USA, LLC | $155.70 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $101.62 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $43.52 | 2019-2020 | |
| Sanofi Pasteur INC. | $30.03 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $28.02 | 2020 | |
| Amarin Pharma, INC. | $20.20 | 2019 | |
| Radius Health, INC. | $16.84 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.06 | 2019 | |
| Novo Nordisk INC | $14.57 | 2019 | |
| Abbvie INC. | $13.27 | 2023 | Qulipta |
| Sanofi-Aventis U.S. LLC | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Bugay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.